[HTML][HTML] Dodging blood brain barrier with “nano” warriors: Novel strategy against ischemic stroke
Ischemic stroke (IS) is one of the leading causes of death and disability resulting in
inevitable burden globally. Ischemic injury initiates cascade of pathological events …
inevitable burden globally. Ischemic injury initiates cascade of pathological events …
[HTML][HTML] The balancing act of NEET proteins: Iron, ROS, calcium and metabolism
NEET proteins belong to a highly conserved group of [2Fe–2S] proteins found across all
kingdoms of life. Due to their unique [2Fesingle bond2S] cluster structure, they play a key …
kingdoms of life. Due to their unique [2Fesingle bond2S] cluster structure, they play a key …
Blocking P2RX7 attenuates ferroptosis in endothelium and reduces HG-induced hemorrhagic transformation after MCAO by inhibiting ERK1/2 and P53 signaling …
C Liu, Q Tian, J Wang, P He, S Han, Y Guo… - Molecular …, 2023 - Springer
Hyperglycemia is a risk factor for poor prognosis after acute ischemic stroke and promote the
occurrence of hemorrhagic transformation (HT). The activation of P2RX7 play an important …
occurrence of hemorrhagic transformation (HT). The activation of P2RX7 play an important …
[HTML][HTML] The application of nanotechnology for the diagnosis and treatment of brain diseases and disorders
EE Ngowi, YZ Wang, L Qian, YASH Helmy… - … in Bioengineering and …, 2021 - frontiersin.org
Brain is by far the most complex organ in the body. It is involved in the regulation of
cognitive, behavioral, and emotional activities. The organ is also a target for many diseases …
cognitive, behavioral, and emotional activities. The organ is also a target for many diseases …
Ischemia reperfusion injury: Opportunities for nanoparticles
X Zang, J Zhou, X Zhang, Y Han… - ACS biomaterials science …, 2020 - ACS Publications
Ischemia reperfusion (IR)-induced oxidative stress, accompanied by inflammatory
responses, contributes to morbidity and mortality in numerous diseases such as acute …
responses, contributes to morbidity and mortality in numerous diseases such as acute …
The recent applications of plga-based nanostructures for ischemic stroke
J Yan, L Huang, J Feng, X Yang - Pharmaceutics, 2023 - mdpi.com
With the accelerated development of nanotechnology in recent years, nanomaterials have
become increasingly prevalent in the medical field. The poly (lactic acid–glycolic acid) …
become increasingly prevalent in the medical field. The poly (lactic acid–glycolic acid) …
NL-1 promotes PINK1-Parkin-mediated mitophagy through MitoNEET inhibition in subarachnoid hemorrhage
T Zhang, M Zhang - Neurochemical research, 2024 - Springer
NL-1 is a mitoNEET ligand known for its antileukemic effects and has recently shown
neuroprotective effects in an ischemic stroke model. However, its underlying process in …
neuroprotective effects in an ischemic stroke model. However, its underlying process in …
Surface-Tailored Nanoplatform for the Diagnosis and Management of Stroke: Current Strategies and Future Outlook
H Shah, G Paul, AK Yadav - Molecular Neurobiology, 2024 - Springer
Stroke accounts for one of the top leading reasons for neurological mortality and morbidity
around the globe. Both ischemic and hemorrhagic strokes lead to local hypoxia and are …
around the globe. Both ischemic and hemorrhagic strokes lead to local hypoxia and are …
The mitochondrial mitoNEET ligand NL-1 is protective in a murine model of transient cerebral ischemic stroke
P Saralkar, A Mdzinarishvili, TA Arsiwala, YK Lee… - Pharmaceutical …, 2021 - Springer
Purpose Therapeutic strategies to treat ischemic stroke are limited due to the heterogeneity
of cerebral ischemic injury and the mechanisms that contribute to the cell death. Since …
of cerebral ischemic injury and the mechanisms that contribute to the cell death. Since …
Novel mitoNEET ligand NL-1 improves therapeutic outcomes in an aged rat model of cerebral ischemia/reperfusion injury
A Vijikumar, P Saralkar, SD Saylor, PG Sullivan… - Experimental …, 2022 - Elsevier
Cerebral ischemic stroke is a leading cause of mortality and disability worldwide. Currently,
there are a lack of drugs capable of reducing neuronal cell loss due to ischemia/reperfusion …
there are a lack of drugs capable of reducing neuronal cell loss due to ischemia/reperfusion …